Virginia Recovery Guide is operated by Treatment Outreach (TOS). We are not a medical provider, hospital, government agency, or emergency service. In a crisis, call or text 988. In an emergency, call 911.

Paying for Suboxone, methadone or Vivitrol in Virginia: a coverage-first guide

For many Virginians, the barrier to opioid treatment is not deciding to start. It is not knowing whether they can afford it, or whether a prior authorization will stall things for a week. Virginia publishes more detail on this than most states, so this guide starts with the money: what Virginia Medicaid says it covers, which medications skip prior authorization, what the uninsured can do, and then how to pick a setting and find a program.

Virginia Recovery Guide is run by Treatment Outreach, an independent service. We do not prescribe or dispense medication, and we cannot promise what any plan will pay. Coverage depends on your plan and on clinical need, so confirm with the program and your plan before you start.

If you have Virginia Medicaid (Cardinal Care)

Virginia Medicaid covers substance use treatment through its Addiction and Recovery Treatment Services (ARTS) benefit, run by the Department of Medical Assistance Services (DMAS). Three points from DMAS's own documents matter most for medication treatment.

1. No service authorization for the two medication settings. The ARTS provider manual (Chapter IV, updated July 7, 2025) lists service authorization requirements by level of care. Residential, partial hospitalization and intensive outpatient care need it. Opioid treatment programs (OTPs) and preferred office-based addiction treatment (OBAT) are listed as not requiring it.

2. Preferred buprenorphine without prior authorization. DMAS's opioid use disorder drug list for fee-for-service and Cardinal Care managed care (last updated January 1, 2026) says these do not need prior authorization when prescribed by an in-network Medicaid prescriber following the Board of Medicine's buprenorphine rules:

  • Suboxone sublingual film, under 24 mg a day
  • generic buprenorphine/naloxone sublingual tablets, under 24 mg a day
  • buprenorphine sublingual "mono-product," covered only during pregnancy, for up to 10 months
  • the monthly injections Sublocade and Brixadi

The same list says Vivitrol (extended-release naltrexone) and naltrexone tablets may be written by any in-network Medicaid prescriber. Products that do need prior authorization include generic buprenorphine/naloxone film, Zubsolv and the Probuphine implant. Formularies change, so ask the pharmacist to run the claim before you leave the prescriber's office.

3. Preferred OBAT can be close to home. Under 12VAC30-130-5060, preferred OBAT can be offered in primary care clinics, health system outpatient clinics, psychiatry clinics, federally qualified health centers, community services boards, local health department clinics and physician offices, by a prescriber with a DEA registration covering Schedule III drugs. Medication is dispensed on site only during the start-up (induction) phase; after that it is prescribed. Counseling is part of the model and can be delivered by telemedicine when it meets DMAS rules.

Our Cardinal Care guide explains eligibility and how to apply.

If you have no insurance

Start with your local community services board (CSB). In a January 2024 fact sheet, the Department of Behavioral Health and Developmental Services (DBHDS) said all 40 CSBs offer referrals for medication treatment, either in house or through an agreement with a provider, and that the state had directed money to private OTPs to help uninsured and underinsured Virginians. Funding amounts change year to year, so ask the CSB what is available now. Our guide to getting into rehab in Virginia explains how CSB same-day access works.

If you have commercial insurance, our page on insurance and paying for treatment lists the questions to ask your plan.

Choosing the setting: OTP or office-based

Methadone means an OTP. DBHDS states that methadone can only be prescribed in a licensed opioid treatment program, and that Virginia OTPs are licensed by DBHDS and the Board of Pharmacy as well as by DEA and SAMHSA. DBHDS's licensing regulations include specific standards for new OTP licenses (12VAC35-105-925), and SAMHSA lists DBHDS as Virginia's state opioid treatment authority. OTPs can also provide buprenorphine and naltrexone.

Buprenorphine can come from many places. DBHDS notes buprenorphine can be prescribed in an OTP, an OBAT or by other prescribers. Federally, SAMHSA says the Consolidated Appropriations Act of 2023 ended the separate "X-waiver"; a practitioner with a DEA registration that includes Schedule III may prescribe buprenorphine for opioid use disorder where state law allows. Virginia's Board of Medicine rule (18VAC85-21-130) requires prescribers to offer counseling or a referral, but says a patient's refusal of counseling does not by itself prevent office-based buprenorphine treatment. Physician assistants prescribe it under a practice agreement.

Telehealth. The DEA's COVID-era telemedicine flexibilities are extended through December 31, 2026, which allows buprenorphine for opioid use disorder to be prescribed by audio-video or audio-only visit without a prior in-person exam, if federal and state rules are met. A separate federal final rule allows a telehealth start and up to a six-month total supply before an in-person evaluation or another authorized option is needed.

What daily life at an OTP looks like

SAMHSA describes methadone as a long-acting medication taken daily, available in liquid, powder and diskette forms, and says patients may take doses home after a period of stability. Federal rules revised in 2024 cap take-home supplies at 7 days during the first 14 days of treatment, 14 days from day 15 and 28 days from day 31, at the practitioner's clinical discretion.

Finding a program

SAMHSA's Opioid Treatment Program Directory listed 60 Virginia programs as of its October 30, 2026 update (51 fully certified, 9 provisionally certified). Richmond had the most (7), followed by Winchester (4), Norfolk and Newport News (3 each), with others from Virginia Beach and Fredericksburg to Roanoke, Danville and Galax. FindTreatment.gov also lists office-based prescribers. Our pages for Richmond, Chesterfield, Fairfax, Prince William and Virginia Beach list local options, and you can check a program's license.

Protect against overdose

SAMHSA warns that tolerance falls after a period without opioids, so returning to an old dose can be fatal. Do not stop or change medication without your prescriber. Keep naloxone at home; Cardinal Care's list includes several naloxone products, and our Virginia naloxone guide explains other ways to get it. Families can read our guide to helping a loved one with addiction. In a crisis, call or text 988. In an emergency, call 911.

Frequently asked questions

Does Virginia Medicaid require prior authorization for Suboxone?

DMAS's January 1, 2026 list says Suboxone film and generic buprenorphine/naloxone tablets under 24 mg a day do not need prior authorization when prescribed by an in-network Medicaid prescriber following Board of Medicine rules. Generic buprenorphine/naloxone film does.

Do I need approval before starting at a methadone clinic on Medicaid?

The ARTS provider manual lists opioid treatment programs and preferred office-based addiction treatment as not requiring service authorization. Coverage still depends on eligibility and medical necessity.

Can I get methadone from a regular doctor in Virginia?

No. DBHDS says methadone for opioid use disorder can only be prescribed in a licensed opioid treatment program.

What if I don't have insurance?

Contact your community services board. DBHDS has said all 40 CSBs offer referrals for medication treatment, and some state funding has gone to help uninsured patients at private OTPs.

Do I have to attend counseling to get buprenorphine?

Virginia's Board of Medicine rule says prescribers must offer counseling or a referral, but a patient's refusal does not by itself bar office-based buprenorphine treatment.

Sources

Last updated . Clinical review pending. This page is general information, not medical advice.

Call (844) 933-3846 now